Exhibit 99.4

WNS (HOLDINGS) LIMITED
FORM OF PROXY
FOR THE ANNUAL GENERAL MEETING
To be held on September 24, 2020
For use at the Annual General Meeting of the shareholders of WNS (Holdings) Limited (the “Company”) to be held at 11:00 a.m. G.M.T on Thursday, September 24, 2020 and any adjournment thereof.
I/We [insert name] of [address] (BLOCK LETTERS PLEASE), being (a) shareholder(s) of the above named Company, hereby appoint the Chairman of the Annual General Meeting as my/our proxy to vote for me/us and on my/our behalf at the Annual General Meeting of the Company to be held at am G.M.T on day, and at any adjournment thereof or on a poll in respect of [insert number]** ordinary shares in the capital of the Company.
** | You will need to specify the number of ordinary shares in respect of which the named proxy is entitled to vote. |
I / We direct my / our proxy to vote as follows:-
| | | | | | |
ORDINARY RESOLUTIONS | | FOR | | AGAINST | | ABSTAIN |
1. Adoption of annual audited accounts for the financial year ended March 31, 2020 | | | | | | |
2. Re-appointment of Grant Thornton India LLP as the auditors of the Company | | | | | | |
3. Approval of auditors’ remuneration for the financial year ending March 31, 2021 | | | | | | |
4. Re-election of Mr. Michael Menezes as a Class II Director of the Company | | | | | | |
5. Re-election of Mr. Keith Haviland as a Class II Director of the Company | | | | | | |
6. Re-election of Mr. Keshav R. Murugesh as a Class II Director of the Company | | | | | | |
7. Approval of Directors’ remuneration for the period from the Annual General Meeting until the next annual general meeting of the Company to be held in respect of the financial year ending March 31, 2021 | | | | | | |
8. Increase in the Ordinary Shares/American Depositary Shares, (“ADSs”) available for grant under the Company’s 2016 Incentive Award Plan as may be amended and restated pursuant to and in accordance with terms thereof (“the 2016 Incentive Award Plan”) by 2.2 Million Ordinary Shares/ADSs (representing 4.4% of the total outstanding share capital as at June 30, 2020) and the adoption of Company’s Second Amended and Restated 2016 Incentive Award Plan to reflect such increase, substantially in the form set out in Appendix B to this Proxy Statement; and | | | | | | |
9. To authorize the purchase of ADSs, effective April 1, 2021 (“The Effective date”) and up to (and excluding) the date of third anniversary of the Effective Date, subject to minimum and maximum price and an aggregate limit on the ADSs to be purchased (the “Repurchase Plan”) | | | | | | |
Date: , 2020
Signature of Shareholder/Authorized Signatory
(If you are signing this form as a director or officer of a body corporate or other entity, please indicate in what capacity you are signing and who you are signing for e.g. “Director of X Limited” or “Director of X Limited as general partner of Y Limited Partnership”).
1